Standard versus intensive therApy by Rosuvastatin for lipiD lowering

Trial Profile

Standard versus intensive therApy by Rosuvastatin for lipiD lowering

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Jun 2014

At a glance

  • Drugs Rosuvastatin (Primary)
  • Indications Hyperlipidaemia
  • Focus Therapeutic Use
  • Acronyms SARD
  • Most Recent Events

    • 02 Dec 2013 Last checked against University Hospital Medical Information Network - Japan record.
    • 30 Nov 2012 Planned End Date changed from 1 Mar 2013 to 30 Dec 2012 as reported by University Hospital Medical Information Network - Japan record..
    • 03 Sep 2012 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top